Clinical trial
Determining the Success of a Urine Metabolite Point-of-care Colorectal Cancer Early Diagnosis Test in Africa
NCT07649057 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining the Success of a Urine Metabolite Point-of-care Colorectal Cancer Early Diagnosis Test in Africa
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 11, 2026
- Completion date
- June 11, 2028
- Enrollment
- 210 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, crc, precancerous polyp, rectal bleeding